Millennium Management’s Aerie Pharmaceuticals AERI Stock Holding History

Millennium Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22,500	Closed	-$849K	–	3858
2016 Q3	$849K	Buy	+22,500	New	+$496K	﹤0.01%	2347

Millennium Management's AERI Position: Q4 2022 in Review

Millennium Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 118,240 shares — an estimated $1.79M sold.

Millennium Management first reported a position in AERI in Q4 2013 and held it in 31 quarters. The position peaked at $49.3M in Q1 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Millennium Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 118,240 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.79M.
Millennium Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 31 quarters.
Millennium Management's Aerie Pharmaceuticals position peaked at $49.3M in Q1 2017.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.